Open label research for
cerebral palsy

A NeuroCytonix and Sparo Foundation* Partnership
Donate for open label research on Cerebral Palsy

children in grass.jpg

Help with our first cerebral palsy program

NeuroCytonix has completed its first FDA-supervised, double blind, randomized, placebo-controlled clinical trial. This trial measured the safety and efficacy of NeuroCytonix’s protocols for fifty Mexican children with cerebral palsy.  

 

Prior to the study, many children with cerebral palsy has remarkable improvements after treatment with our cutting-edge technology.

 

Now that the supervised trial is complete, NeuroCytonix would like to provide effectual care for the 25 children who received placebo treatments. We are looking for financial support to cover the costs to the children’s families who could not otherwise afford the treatment

Please click on the Donate button and become a donor to this worthy cause. Your donation will be tax deductible.

NeuroCytonix has partnered with Sparo Foundation

NeuroCytonix has selected Maryland based Sparo Foundation as its Corporate Social Responsibility (CSR) partner to bring attention to and raise funds for children and adults with brain disorders. 

Sparo will assist NeuroCytonix in raising tax deductible donations from charities and individual donors for follow on open label research program on Cerebral Palsy and other brain diseases.

family on the beach.jpg

*Sparo Foundation is the non-profit arm of Sparo Corporation. Sparo is a Microsoft for Startups company.